ABG
Ally Bridge Group Portfolio holdings
AUM
$114M
This Quarter Return
+0.69%
1 Year Return
+41.64%
3 Year Return
+246.39%
5 Year Return
–
10 Year Return
–
AUM
$305M
AUM Growth
+$305M
(-14%)
Cap. Flow
-$11.4M
Cap. Flow
% of AUM
-3.75%
Top 10 Holdings %
Top 10 Hldgs %
57.82%
Holding
36
New
8
Increased
4
Reduced
7
Closed
6
Top Buys
| 1 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
$9.91M |
| 2 |
Rapid Micro Biosystems
RPID
|
$8.09M |
| 3 |
Sight Sciences
SGHT
|
$7.77M |
| 4 |
Natera
NTRA
|
$5.57M |
| 5 |
MacroGenics
MGNX
|
$5.28M |
Top Sells
| 1 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$17.3M |
| 2 |
ESSA Pharma
EPIX
|
$10.4M |
| 3 |
Atea Pharmaceuticals
AVIR
|
$8.02M |
| 4 |
CYT
Cyteir Therapeutics, Inc. Common Stock
CYT
|
$5.39M |
| 5 |
Apellis Pharmaceuticals
APLS
|
$5.37M |
Sector Composition
| 1 | Healthcare | 96.55% |
| 2 | Materials | 1.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Natera
NTRA
$23.1B
| $29.9M | 8.78% | 268,000 +50,000 | +23% | +$5.57M |
|
2
Repligen
RGEN
$6.88B
| $20.2M | 5.95% | 70,000 -12,500 | -15% | -$3.61M |
|
3
Arvinas
ARVN
$568M
| $17.3M | 5.07% | 210,000 -30,000 | -13% | -$2.47M |
|
|
MRTX
4
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $16.8M | 4.94% | 95,000 | – | – |
|
5
Nuvation Bio
NUVB
$1.02B
| $16.5M | 4.85% | 1,660,947 -47,144 | -3% | -$469K |
|
6
Fate Therapeutics
FATE
$120M
| $16M | 4.71% | 270,000 | – | – |
|
|
SYRS
7
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $15.4M | 4.52% | 3,439,895 | – | – |
|
8
Viridian Therapeutics
VRDN
$1.5B
| $14.9M | 4.38% | 904,978 +45,068 | +5% | +$741K |
|
9
Gossamer Bio
GOSS
$562M
| $14.8M | 4.34% | 1,175,000 | – | – |
|
10
IDEAYA Biosciences
IDYA
$2.15B
| $14.7M | 4.32% | 575,940 +65,533 | +13% | +$1.67M |
|
11
Cogent Biosciences
COGT
$1.69B
| $13.6M | 4.01% | 1,622,591 | – | – |
|
12
Iovance Biotherapeutics
IOVA
$807M
| $10M | 2.95% | 406,986 | – | – |
|
|
SLGC
13
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $9.91M | 2.91% | +800,000 | New | +$9.91M |
|
14
Nautilus Biotechnolgy
NAUT
$85.9M
| $9.21M | 2.71% | 1,500,000 | – | – |
|
|
NSTG
15
DELISTED
NanoString Technologies, Inc.
NSTG
| $8.88M | 2.61% | 185,000 | – | – |
|
16
Intellia Therapeutics
NTLA
$1.22B
| $8.72M | 2.56% | 65,000 -28,127 | -30% | -$3.77M |
|
|
MDVL
17
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $8.53M | 2.51% | 2,920,780 | – | – |
|
|
18
Rapid Micro Biosystems
RPID
$107M
| $8.09M | 2.38% | +437,960 | New | +$8.09M |
|
|
19
Sight Sciences
SGHT
$213M
| $7.77M | 2.28% | +342,304 | New | +$7.77M |
|
|
20
MacroGenics
MGNX
$112M
| $7.64M | 2.25% | 365,000 +252,161 | +223% | +$5.28M |
|
|
NVTA
21
DELISTED
Invitae Corporation
NVTA
| $5.68M | 1.67% | 199,900 -100,100 | -33% | -$2.85M |
|
|
CYT
22
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $5.61M | 1.65% | 319,538 -307,305 | -49% | -$5.39M |
|
|
AMRS
23
DELISTED
Amyris Inc.
AMRS
| $4.84M | 1.42% | +352,445 | New | +$4.84M |
|
24
Leap Therapeutics
LPTX
$12M
| $4.81M | 1.41% | +1,200,000 | New | +$4.81M |
|
|
ISEE
25
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $4.06M | 1.19% | +250,000 | New | +$4.06M |
|